发明名称 STABILIZED PHARMACEUTICAL COMPOSITION
摘要 <P>PROBLEM TO BE SOLVED: To provide a pharmaceutical composition suppressing increase of impurities accompanying formulation of statin drugs typified by atorvastatin or derivatives thereof and preventing reduction in a content with time; a method for preparing the composition; and use of the composition. <P>SOLUTION: When calcium sulfate is combined with a statin drug or a derivative thereof, a stable preparation is obtained. That is, by addition of calcium sulfate, decomposition of active ingredients is greatly prevented, increase of impurities accompanying formulation is suppressed, and reduction with time in a content of the active ingredients can be prevented. <P>COPYRIGHT: (C)2013,JPO&INPIT
申请公布号 JP2013035770(A) 申请公布日期 2013.02.21
申请号 JP20110172000 申请日期 2011.08.05
申请人 TEVA PHARMA JAPAN INC 发明人 INOUE KATSUHISA;ISODA HIDEYUKI
分类号 A61K31/40;A61K9/20;A61K47/04;A61P3/06;A61P13/08;A61P19/10;A61P25/28 主分类号 A61K31/40
代理机构 代理人
主权项
地址
您可能感兴趣的专利